Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

MLA

Peter Mugyenyi, et al. “Second-Line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.” Journal of Tropical Pediatrics, Sept. 2016, p. fmw062. EBSCOhost, https://doi.org/10.1093/tropej/fmw062.

APA

Peter Mugyenyi, Joshua Kayiwa, Lilian Nakatudde, Victor Musiime, Ragna S. Boerma, Job C. J. Calis, Mary Kiconco, Michael Boele van Hensbroek, T. Sonia Boender, Immaculate Nankya, Cissy Kityo, Elizabeth Kaudha, Andrew Mukuye, Kim C. E. Sigaloff, & Tobias F. Rinke de Wit. (2016). Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance. Journal of Tropical Pediatrics, fmw062. https://doi.org/10.1093/tropej/fmw062

Chicago

Peter Mugyenyi, Joshua Kayiwa, Lilian Nakatudde, Victor Musiime, Ragna S. Boerma, Job C. J. Calis, Mary Kiconco, et al. 2016. “Second-Line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.” Journal of Tropical Pediatrics, September, fmw062. doi:10.1093/tropej/fmw062.